La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « PascalFr.i » - entrée « Psychotrope »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Psychothérapie < Psychotrope < Pupillométrie  Facettes :

List of bibliographic references indexed by Psychotrope

Number of relevant bibliographic references: 31.
[0-20] [0 - 20][0 - 31][20-30][20-40]
Ident.Authors (with country if any)Title
000B85 (2014) Michel Panisset [Canada] ; Jack J. Chen [États-Unis] ; Sean H. Rhyee [États-Unis] ; Jill Conner [États-Unis] ; Julie Mathena [États-Unis]Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO)
001038 (2013) James B. Koprich [Canada] ; Philippe Huot [Canada] ; Susan H. Fox [Canada] ; Keith Jarvie [Canada] ; Anthony E. Lang [Canada] ; Philip Seeman [Canada] ; Jonathan M. Brotchie [Canada]The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques
001062 (2013) Philip Seeman [Canada] ; Michele Tinazzi [Italie]Loss of dopamine neuron terminals in antipsychotic-treated schizophrenia; relation to tardive dyskinesia
001082 (2013) Mee-Sook Song [Canada] ; Dmitriy Matveychuk [Canada] ; Erin M. Mackenzie [Canada] ; Maryana Duchcherer [Canada] ; Darrell D. Mousseau [Canada] ; Glen B. Baker [Canada]An update on amine oxidase inhibitors: Multifaceted drugs
001515 (2012) Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Jenna Sykes [Canada] ; Stephen J. Kish [Canada]Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs
001541 (2012) Pierre J. Blanchet [Canada] ; Louise Normandeau [Canada] ; Pierre H. Rompre [Canada]Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: A pilot study
001961 (2011) Sara Kost [Canada] ; CHAO SUN [Canada] ; WEI XIONG [Canada] ; Kathryn Graham [Canada] ; Carol E. Cass [Canada] ; James D. Young [Canada] ; Benedict C. Albensi [Canada] ; Fiona E. Parkinson [Canada]Behavioral effects of elevated expression of human equilibrative nucleoside transporter 1 in mice
001D45 (2010) Andrew R. Brown [Canada] ; BIN HU [Canada] ; Bryan Kolb [Canada] ; G. Campbell Teskey [Canada]Acoustic tone or medial geniculate stimulation cue training in the rat is associated with neocortical neuroplasticity and reduced akinesia under haloperidol challenge
002078 (2009) Pierre-Luc Tremblay [Canada] ; Marc-Andre Bedard [Canada] ; Maxime Levesque [Canada] ; Mark Chebli [Canada] ; Maxime Parent [Canada] ; Richard Courtemanche [Canada] ; Pierre J. Blanchet [Canada]Motor sequence learning in primate : Role of the D2 receptor in movement chunking during consolidation
002105 (2009) Jennifer R. St. Onge [Canada] ; Stan B. Floresco [Canada]Dopaminergic Modulation of Risk-Based Decision Making
002613 (2007) Valerie Voon [États-Unis, Canada] ; Susan Fox [Canada] ; Tracy R. Butler [États-Unis] ; Anthony E. Lang [Canada]Antidepressants and psychosis in Parkinson disease: a case series
002638 (2007) Mélanie Bourque [Canada] ; BIN LIU [États-Unis] ; Dean E. Dluzen [États-Unis] ; Therese Di Paolo [Canada]Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity
002651 (2007) Michelle R. Ciucci [États-Unis] ; Sean T. Ma [États-Unis] ; Cynthia Fox [États-Unis] ; Jacqueline R. Kane [États-Unis] ; Lorraine O. Ramig [États-Unis] ; Timothy Schallert [États-Unis]Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol : A preliminary study
002932 (2006) Andrew R. Willan [Canada] ; Ron Goeree [Canada] ; Eleanor M. Pullenayegum [Canada] ; Christopher Mcburney [États-Unis] ; Gordon Blackhouse [Canada]Economic evaluation of rivastigmine in patients with parkinson's disease dementia
002B17 (2005) Guy Chouinard [Canada] ; Howard C. Margolese [Canada]Manual for the Extrapyramidal Symptom Rating Scale (ESRS)
002B48 (2005) Brad Hagen [Canada] ; Chris Armstrong Esther [Canada] ; Roland Ikuto [Canada] ; Robert J. Williams [Canada] ; Carole-Lynne Le Navenec [Canada] ; Morgan AhoAntipsychotic drug use in Canadian long-term care facilities : prevalence, and patterns following resident relocation
002D06 (2004) Murat Emre [Turquie] ; Dag Aarsland [Norvège] ; Albeao Albanese [Italie] ; E. Jane Byrne [Royaume-Uni] ; Günther Deuschl [Allemagne] ; Peter P. De Deyn [Belgique] ; Franck Durif [France] ; Jaime Kulisevsky [Espagne] ; Teus Van Laar [Pays-Bas] ; Andrew Lees [Royaume-Uni] ; Werner Poewe [Autriche] ; Alain Robillard [Canada] ; Mario M. Rosa [Portugal] ; Erik Wolters [Pays-Bas] ; Peter Quarg [Suisse] ; Sibel Tekin [États-Unis] ; Roger Lane [États-Unis]Rivastigmine for dementia associated with Parkinson's disease
002D24 (2004) Erwan Bezard [France] ; Michael P. Hill [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Anne Michel [Belgique] ; Renee Grimee [Belgique] ; Henrik Klitgaard [Belgique]Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque
003049 (2002) Anette V. Nieves [Canada, États-Unis] ; Anthony E. Lang [Canada]Treatment of excessive daytime sleepiness in patients with Parkinson's Disease with modafinil
003058 (2002) Vincenzo Di Matteo [Italie] ; Marisa Cacchio [Italie] ; Camillo Di Giulio [Italie] ; Ennio Esposito [Italie]Role of serotonin2C receptors in the control of brain dopaminergic function
003351 (2001) Raul De La Fuente-Fernandez [Canada] ; Jian-Qiang Lu [Canada] ; Vesna Sossi [Canada] ; Salma Jivan [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Chong S. Lee [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease : PET evidence of increased dopamine turnover

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Psychotrope" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Psychotrope" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Psychotrope
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022